​

Minerva Neurosciences (NERV) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

NERV Stock Forecast

Minerva Neurosciences (NERV) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $5.00, with a high of $5.00 and a low of $5.00. This represents a 19.90% increase from the last price of $4.17.

$2 $3 $4 $5 $6 $7 High: $5 Avg: $5 Low: $5 Last Closed Price: $4.17

NERV Stock Rating

Minerva Neurosciences stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (71.43%), 2 Hold (28.57%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 2 5 Strong Sell Sell Hold Buy Strong Buy

NERV Price Target Upside V Benchmarks

TypeNameUpside
StockMinerva Neurosciences19.90%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-11
Avg Price Target-$5.00$5.00
Last Closing Price$4.17$4.17$4.17
Upside/Downside-19.90%19.90%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 26--2--2
Dec, 25--2--2
Nov, 25--1--1
May, 25--1--1
Apr, 25--1--1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 01, 2025Jefferies$5.00$3.8031.58%19.90%
Aug 07, 2024Douglas TsaoH.C. Wainwright$5.00$2.9470.07%19.90%
May 02, 2024Douglas TsaoH.C. Wainwright$7.00$2.40191.67%67.87%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 01, 2025JefferiesHoldHoldhold
Aug 07, 2024H.C. WainwrightNeutralNeutralhold
May 02, 2024H.C. WainwrightNeutralNeutralhold

Financial Forecast

EPS Forecast

$-50 $0 $50 $100 $150 $200 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-9.35$-4.61$190.10----
Avg Forecast$-6.81$-4.26$-0.30$-2.68$-1.88$1.42$1.62
High Forecast$-6.81$-4.26$-0.30$-2.68$-1.88$1.42$1.62
Low Forecast$-6.81$-4.26$-0.30$-2.68$-1.88$1.42$1.62
Surprise %37.30%8.22%-63466.67%----

Revenue Forecast

$0 $30M $60M $90M $120M $150M Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-------
Avg Forecast$333.33K-$20.00M$45.19M$19.76M$56.49M$137.88M
High Forecast$333.33K-$20.00M$45.19M$19.76M$56.49M$137.88M
Low Forecast$333.33K-$20.00M$45.19M$19.76M$56.49M$137.88M
Surprise %-------

Net Income Forecast

$-500M $-100M $300M $700M $1B $2B Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-49.91M$-30.01M$1.44B----
Avg Forecast$-44.33M$-27.72M$-1.95M$-17.44M$-12.23M$9.24M$10.54M
High Forecast$-44.33M$-27.72M$-1.95M$-17.44M$-12.23M$9.24M$10.54M
Low Forecast$-44.33M$-27.72M$-1.95M$-17.44M$-12.23M$9.24M$10.54M
Surprise %12.59%8.26%-73815.71%----

NERV Forecast FAQ

Is Minerva Neurosciences stock a buy?

Minerva Neurosciences stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Minerva Neurosciences is a favorable investment for most analysts.

What is Minerva Neurosciences's price target?

Minerva Neurosciences's price target, set by 7 Wall Street analysts, averages $5 over the next 12 months. The price target range spans from $5 at the low end to $5 at the high end, suggesting a potential 19.90% change from the previous closing price of $4.17.

How does Minerva Neurosciences stock forecast compare to its benchmarks?

Minerva Neurosciences's stock forecast shows a 19.90% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Minerva Neurosciences over the past three months?

  • January 2026: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is Minerva Neurosciences’s EPS forecast?

Minerva Neurosciences's average annual EPS forecast for its fiscal year ending in December 2025 is $-2.68, marking a -101.41% decrease from the reported $190.1 in 2024. Estimates for the following years are $-1.88 in 2026, $1.42 in 2027, and $1.62 in 2028.

What is Minerva Neurosciences’s revenue forecast?

Minerva Neurosciences's average annual revenue forecast for its fiscal year ending in December 2025 is $45.19M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $19.76M, followed by $56.49M for 2027, and $137.88M for 2028.

What is Minerva Neurosciences’s net income forecast?

Minerva Neurosciences's net income forecast for the fiscal year ending in December 2025 stands at $-17.437M, representing a -101.21% decrease from the reported $1.44B in 2024. Projections indicate $-12.232M in 2026, $9.24M in 2027, and $10.54M in 2028.